BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19554454)

  • 41. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
    Yadav D; Survase S; Kumar N
    Int J Pharm; 2011 Oct; 419(1-2):121-30. PubMed ID: 21807081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and in vitro evaluation of ketoprofen extended release pellets using powder layering technique in a rotary centrifugal granulator.
    Pai R; Pai A; Srivastava B; Kohli K
    Comb Chem High Throughput Screen; 2011 Feb; 14(2):138-45. PubMed ID: 21118082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of water soluble additives and HPMCP on drug release from Surelease-coated pellets containing tamsulosin hydrochloride.
    Kim MS; Kim JS; Kang SH; Yoo YH; Lee S; Park JS; Woo JS; Hwang SJ
    Arch Pharm Res; 2007 Aug; 30(8):1008-13. PubMed ID: 17879755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aqueous ethyl cellulose dispersions containing plasticizers of different water solubility and hydroxypropyl methylcellulose as coating material for diffusion pellets. I. Drug release rates from coated pellets.
    Frohoff-Hülsmann MA; Schmitz A; Lippold BC
    Int J Pharm; 1999 Jan; 177(1):69-82. PubMed ID: 10205604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
    Nguyen C; Christensen JM; Ayres JW
    Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and in-vitro evaluation of modified release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride.
    Sengel CT; Hasçiçek C; Gönül N
    J Microencapsul; 2006 Mar; 23(2):135-52. PubMed ID: 16754371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determinants of zero-order release kinetics from acetaminophen-layered Suglet® pellets, Wurster-coated with plasticized Aquacoat® ECD (ethyl cellulose dispersion).
    Kaur S; Sivasankaran S; Wambolt E; Jonnalagadda S
    Int J Pharm; 2020 Jan; 573():118873. PubMed ID: 31765772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of the porosity of cushioning excipients on the compaction of coated multi-particulates.
    Elsergany RN; Chan LW; Heng PWS
    Eur J Pharm Biopharm; 2020 Jul; 152():218-228. PubMed ID: 32445966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using kappa-carrageenan as a pelletizing agent.
    Kilor VA; Sapkal NP; Awari JG; Shewale BD
    AAPS PharmSciTech; 2010 Mar; 11(1):336-43. PubMed ID: 20195805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug-polymer mixed coating: a new approach for controlling drug release rates in pellets.
    Nisar ur Rahman ; Yuen KH; Khan NA; Wong JW
    Pharm Dev Technol; 2006 Feb; 11(1):71-7. PubMed ID: 16544910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cushioning pellets based on microcrystalline cellulose - Crospovidone blends for MUPS tableting.
    Elsergany RN; Chan LW; Heng PWS
    Int J Pharm; 2020 Aug; 586():119573. PubMed ID: 32599135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers.
    Kranz H; Gutsche S
    Int J Pharm; 2009 Oct; 380(1-2):112-9. PubMed ID: 19632313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fabrication of multiunit controlled-release phenylpropanolamine hydrochloride tablets.
    Mitrevej A; Sinchaipanid N; Natpoolwat N; Naratikornrit N
    Drug Dev Ind Pharm; 1998 Aug; 24(8):793-6. PubMed ID: 9876528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
    Rojas J; Kumar V
    Pharmazie; 2012 Jul; 67(7):595-7. PubMed ID: 22888514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of intragranular porosity on compression behaviour of and drug release from reservoir pellets.
    Tunón A; Gråsjö J; Alderborn G
    Eur J Pharm Sci; 2003 Aug; 19(5):333-44. PubMed ID: 12907284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug release from reservoir pellets compacted with some excipients of different physical properties.
    Tunón A; Börjesson E; Frenning G; Alderborn G
    Eur J Pharm Sci; 2003 Dec; 20(4-5):469-79. PubMed ID: 14659491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudoephedrine hydrochloride sustained-release pellets prepared by a combination of hot-melt subcoating and polymer coating.
    Yang ZY; Lu Y; Tang X
    Drug Dev Ind Pharm; 2008 Dec; 34(12):1323-30. PubMed ID: 18785047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.